MTOR and leukemia: Dysregulation of the PI3K/Akt/mTOR pathway (phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)) as one of the TGF-β intracellular signals has been reported in leukemia.152